EGIS | HOME

Egis Health and Prevention Days in Kőbánya. In parallel to our mission, we serve people with all our knowledge and skills, so that they can live a long and healthy life. As Diamond Sponsor of the comprehensive nationwide health tests program, Egis Pharmaceuticals is devotedly engaged in the improvement of the Hungarian healthcare. EGIS | PHARMA COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

EGIS | CONTACT

Phone. +36 1 803-5555. Telefax. +36 1 803-5529, +36 1 803-5511. E-mail. mailbox@egis.hu. Write to us. You can use the following online contact form to send a message to our department that is responsible for the selected topic. Last name*. EGIS | SALES AND MARKETING End of dialog window. Sales and Marketing. Our products are available in over 60 countries; 76% of our revenue is derived from export, 24% from our domestic market. Owing to the well-coordinated operations of our sites in Hungary, our extensive network of external markets, and our subsidiaries and offices operating in 17 countries, we are able EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients. As for HP active ingredients, our employees work completely separated from the substances and use special gloves to manipulate the instruments and equipment EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients.

EGIS | HOME

Egis World. Discover the Hungarian Medicine brand. It has been almost 110 years since dr. Sándor Balla, the Hungarian pharmacist fulfilled his dream and the predeccessor of Egis was established in Budapest. Ever since then, our objective has remained unchanged: to provide Hungarian medicines of the highest quality to people, so that they can EGIS | FŐOLDALTRANSLATE THIS PAGE Egis a világban TDK díjátadó az Egis támogatásával. Az ELTE TTK-n hagyomány, hogy minden évben házi konferencián mérik össze tudásukat, illetve mutatják be kutatási eredményeiket a kémia szakterületen tanuló egyetemi hallgatók. EGIS | EGIS IN RUSSIA Egis in Russia. We have more than 65 years of work in Russian market. All the while, we have been committing to the main strategy, which is based on traditionally close relationship with Russian healthcare professionals, as well as the obligation to provide the latest therapies, products of the highest quality for a wider group of people

in Russia.

EGIS | DOPEGYT 250 MG dopegyt 250 mg. public accessible professional information service

EGIS | HOME

Egis Health and Prevention Days in Kőbánya. In parallel to our mission, we serve people with all our knowledge and skills, so that they can live a long and healthy life. As Diamond Sponsor of the comprehensive nationwide health tests program, Egis Pharmaceuticals is devotedly engaged in the improvement of the Hungarian healthcare. EGIS | PHARMA COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

EGIS | CONTACT

Phone. +36 1 803-5555. Telefax. +36 1 803-5529, +36 1 803-5511. E-mail. mailbox@egis.hu. Write to us. You can use the following online contact form to send a message to our department that is responsible for the selected topic. Last name*. EGIS | SALES AND MARKETING End of dialog window. Sales and Marketing. Our products are available in over 60 countries; 76% of our revenue is derived from export, 24% from our domestic market. Owing to the well-coordinated operations of our sites in Hungary, our extensive network of external markets, and our subsidiaries and offices operating in 17 countries, we are able EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients. As for HP active ingredients, our employees work completely separated from the substances and use special gloves to manipulate the instruments and equipment EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients.

EGIS | HOME

Egis World. Discover the Hungarian Medicine brand. It has been almost 110 years since dr. Sándor Balla, the Hungarian pharmacist fulfilled his dream and the predeccessor of Egis was established in Budapest. Ever since then, our objective has remained unchanged: to provide Hungarian medicines of the highest quality to people, so that they can EGIS | FŐOLDALTRANSLATE THIS PAGE Egis a világban TDK díjátadó az Egis támogatásával. Az ELTE TTK-n hagyomány, hogy minden évben házi konferencián mérik össze tudásukat, illetve mutatják be kutatási eredményeiket a kémia szakterületen tanuló egyetemi hallgatók. EGIS | EGIS IN RUSSIA Egis in Russia. We have more than 65 years of work in Russian market. All the while, we have been committing to the main strategy, which is based on traditionally close relationship with Russian healthcare professionals, as well as the obligation to provide the latest therapies, products of the highest quality for a wider group of people

in Russia.

EGIS | DOPEGYT 250 MG dopegyt 250 mg. public accessible professional information service EGIS | BIOSIMILAR PRODUCTS Since 2013, we have launched four biosimilar products for the therapy of autoimmune, oncology and oncohematology illnesses. From 2010 onwards, we have carried out infrastructure developments at our site in Budapest for this entirely new pharmaceutical area—and have acquired new expertise regarding the analysis, packaging, storage,

logistics

EGIS | SALES AND MARKETING End of dialog window. Sales and Marketing. Our products are available in over 60 countries; 76% of our revenue is derived from export, 24% from our domestic market. Owing to the well-coordinated operations of our sites in Hungary, our extensive network of external markets, and our subsidiaries and offices operating in 17 countries, we are able EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients. As for HP active ingredients, our employees work completely separated from the substances and use special gloves to manipulate the instruments and equipment

EGIS | MANAGEMENT

During the more than 100 years since its establishment, Egis has become a leading generic pharmaceutical company in the Central Eastern European region. The composition of our corporate management demonstrates our activities, which extend to every field of the pharmaceutical value chain: from research and development, through

production to

EGIS | PRODUCTS

Prescription products. The majority of our portfolio consists of prescription products that can improve the quality of life for patients suffering with cardiovascular or central nervous system diseases. We are traditionally among the leaders in these two therapeutic areas in Hungary*, and we are continuously exploring new therapeutic areas so EGIS | PERSONALIZED MEDICINE The essence of Personalized Medicine is a reliable diagnostic method connecting the individual interaction between the patient and the medication, facilitating the selection of the effective therapy, reducing side-effects thus supporting the realization of a cost-effective therapy as well. Egis Pharmaceuticals PLC has started

its journey in the

EGIS | OTC PRODUCTS

Here you can find out more about our over-the-counter products. Click on the link and learn about our non-prescription portfolio. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a

valid

EGIS | EGIS WORLD

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | VEZETŐSÉGTRANSLATE THIS PAGE Végzettség: Orvos (SOTE), szakjogász (ELTE), szakközgazdász (BKE), valamint MBA (BME) másoddiploma. Tapasztalatok: 2006 - 2009 Egis nemzetközi értékesítési és marketing igazgató. Korábban üzletág igazgató, Aventisnél & Sanofi-Aventis. Többéves mentőorvosi praktizálás után orvoslátogató, majd termékmenedzserként EGIS | GRATULÁLUNK, EGIS RUSSIA!TRANSLATE THIS PAGE Rangos elismerést nyert oroszországi leányvállalatunk CSR programja. Statisztikai célú sütik A weboldal teljesítményéről (pl. oldalbetöltések száma, oldalon eltöltött átalagos idő) statisztikai adatokat szolgáltat abból a célból, hogy a weboldal üzemeltetője részére adatot gyűjtsön a felhasználók weboldal felhasználási szokásairól.

EGIS | HOME

Egis Health and Prevention Days in Kőbánya. In parallel to our mission, we serve people with all our knowledge and skills, so that they can live a long and healthy life. As Diamond Sponsor of the comprehensive nationwide health tests program, Egis Pharmaceuticals is devotedly engaged in the improvement of the Hungarian healthcare. EGIS | PHARMA COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | BIOSIMILAR PRODUCTS Since 2013, we have launched four biosimilar products for the therapy of autoimmune, oncology and oncohematology illnesses. From 2010 onwards, we have carried out infrastructure developments at our site in Budapest for this entirely new pharmaceutical area—and have acquired new expertise regarding the analysis, packaging, storage,

logistics

EGIS | SALES AND MARKETING End of dialog window. Sales and Marketing. Our products are available in over 60 countries; 76% of our revenue is derived from export, 24% from our domestic market. Owing to the well-coordinated operations of our sites in Hungary, our extensive network of external markets, and our subsidiaries and offices operating in 17 countries, we are able EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients. As for HP active ingredients, our employees work completely separated from the substances and use special gloves to manipulate the instruments and equipment EGIS | EGIS IS THE GOLDEN SPONSOR OF THIS YEAR’S The state-of-the-art screening truck will tour around the country until Christmas, stopping by 200 spots to offer screenings in 37 different areas. Health. Egis is the Golden Sponsor of this Year’s Nationwide Public Health Screening. According to our mission, we serve people with all of our skills, so that they can live a long and

healthy life.

EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients.

EGIS | FLAMMEGIS

Contact. Flammegis. Legal agreement on information. This section of the Egis Pharmaceuticals PLC site contains professional specialized information about medicines, their properties, uses and possible contraindications and other professional specialized information. The information on Egis Pharmaceuticals PLC, including prescription drugs,

is

EGIS | HOME

Egis World. Discover the Hungarian Medicine brand. It has been almost 110 years since dr. Sándor Balla, the Hungarian pharmacist fulfilled his dream and the predeccessor of Egis was established in Budapest. Ever since then, our objective has remained unchanged: to provide Hungarian medicines of the highest quality to people, so that they can EGIS | EGIS IN RUSSIA Egis in Russia. We have more than 65 years of work in Russian market. All the while, we have been committing to the main strategy, which is based on traditionally close relationship with Russian healthcare professionals, as well as the obligation to provide the latest therapies, products of the highest quality for a wider group of people

in Russia.

EGIS | HOME

Egis Health and Prevention Days in Kőbánya. In parallel to our mission, we serve people with all our knowledge and skills, so that they can live a long and healthy life. As Diamond Sponsor of the comprehensive nationwide health tests program, Egis Pharmaceuticals is devotedly engaged in the improvement of the Hungarian healthcare. EGIS | PHARMA COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | BIOSIMILAR PRODUCTS Since 2013, we have launched four biosimilar products for the therapy of autoimmune, oncology and oncohematology illnesses. From 2010 onwards, we have carried out infrastructure developments at our site in Budapest for this entirely new pharmaceutical area—and have acquired new expertise regarding the analysis, packaging, storage,

logistics

EGIS | SALES AND MARKETING End of dialog window. Sales and Marketing. Our products are available in over 60 countries; 76% of our revenue is derived from export, 24% from our domestic market. Owing to the well-coordinated operations of our sites in Hungary, our extensive network of external markets, and our subsidiaries and offices operating in 17 countries, we are able EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients. As for HP active ingredients, our employees work completely separated from the substances and use special gloves to manipulate the instruments and equipment EGIS | EGIS IS THE GOLDEN SPONSOR OF THIS YEAR’S The state-of-the-art screening truck will tour around the country until Christmas, stopping by 200 spots to offer screenings in 37 different areas. Health. Egis is the Golden Sponsor of this Year’s Nationwide Public Health Screening. According to our mission, we serve people with all of our skills, so that they can live a long and

healthy life.

EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients.

EGIS | FLAMMEGIS

Contact. Flammegis. Legal agreement on information. This section of the Egis Pharmaceuticals PLC site contains professional specialized information about medicines, their properties, uses and possible contraindications and other professional specialized information. The information on Egis Pharmaceuticals PLC, including prescription drugs,

is

EGIS | HOME

Egis World. Discover the Hungarian Medicine brand. It has been almost 110 years since dr. Sándor Balla, the Hungarian pharmacist fulfilled his dream and the predeccessor of Egis was established in Budapest. Ever since then, our objective has remained unchanged: to provide Hungarian medicines of the highest quality to people, so that they can EGIS | EGIS IN RUSSIA Egis in Russia. We have more than 65 years of work in Russian market. All the while, we have been committing to the main strategy, which is based on traditionally close relationship with Russian healthcare professionals, as well as the obligation to provide the latest therapies, products of the highest quality for a wider group of people

in Russia.

EGIS | BIOSIMILAR PRODUCTS Since 2013, we have launched four biosimilar products for the therapy of autoimmune, oncology and oncohematology illnesses. From 2010 onwards, we have carried out infrastructure developments at our site in Budapest for this entirely new pharmaceutical area—and have acquired new expertise regarding the analysis, packaging, storage,

logistics

EGIS | EGIS HISTORY

Egis History. The most important milestones in the history of Egis. 1913. Establishment of the company. 1926. Presence at the International Humanitarian Exhibition. 1933. Opening our first research laboratory in Budapest. 1937. EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients. As for HP active ingredients, our employees work completely separated from the substances and use special gloves to manipulate the instruments and equipment

EGIS | EGIS HISTORY

The most important milestones in the history of Egis. 1913. Establishment of the company. 1926. Presence at the international “Exhibition on Human Protection”. 1933. Opening our first research laboratory in Budapest. 1937. Ronin: Our First Self-Developed Heterocyclic Sulfonamide Drug. EGIS | FŐOLDALTRANSLATE THIS PAGE Egis | Főoldal. Egis a világban. Termékeink a világ 60 országában elérhetők. A részletekért kattintson ide. Gyógyszeripari vállalat. Tevékenységünk a gyógyszeripari értéklánc összes területét átfogja. A részletekért kattintson ide. Kutatás-fejlesztés. Stratégiánk egyik alappillére az

innováció.

EGIS | FLAMMEGIS

Contact. Flammegis. Legal agreement on information. This section of the Egis Pharmaceuticals PLC site contains professional specialized information about medicines, their properties, uses and possible contraindications and other professional specialized information. The information on Egis Pharmaceuticals PLC, including prescription drugs,

is

EGIS | OTC PRODUCTS

Here you can find out more about our over-the-counter products. Click on the link and learn about our non-prescription portfolio. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a

valid

EGIS | PHARMACEUTICAL COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

EGIS | EGIS WORLD

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | VEZETŐSÉGTRANSLATE THIS PAGE Végzettség: Orvos (SOTE), szakjogász (ELTE), szakközgazdász (BKE), valamint MBA (BME) másoddiploma. Tapasztalatok: 2006 - 2009 Egis nemzetközi értékesítési és marketing igazgató. Korábban üzletág igazgató, Aventisnél & Sanofi-Aventis. Többéves mentőorvosi praktizálás után orvoslátogató, majd termékmenedzserként

EGIS | HOME

The main page of Egis' international website. Innovation Study on Neuroscience Research wins Egis’ Prize this Year. As research and development are fundamental pillars of our strategy Egis is deeply committed to raise students’ interest in science and help the promising young minds develop their talents. EGIS | PHARMA COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | BIOSIMILAR PRODUCTS Biological therapies made a breakthrough in the treatment of diseases that were incurable or difficult to cure before (e.g. cancer or chronic inflammation). EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Its aim is to analyse the chemical structure, physical characteristics, purity and stability of the selected active substance candidates, and to choose the most suitable form

EGIS | MANAGEMENT

Professional Experience Director of Human Resources Qualification: Teacher of Russian and English language and history (Eger, Miskolc), Certified Human Resource Manager, Doctorate School of the National University of Public Service, Generation research and development performance management and HR controlling expert EGIS | EGIS IS THE GOLDEN SPONSOR OF THIS YEAR’S According to our mission, we serve people with all of our skills, so that they can live a long and healthy life. That is why we chose to support the comprehensive nationwide screening program as a Golden Sponsor in 2019. The state-of-the-art screening truck will tour around the country until Christmas, stopping by 200 spots to offer screenings in 37 different areas. EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients.

EGIS | FLAMMEGIS

This section of the Egis Pharmaceuticals PLC site contains professional specialized information about medicines, their properties, uses and possible contraindications and

EGIS | HOME

The main page of Egis' website. One of the pillars of our corporate culture is innovation. We do not only talk about it, but enjusre the flow of ideas with annual forums that offer space for making proposals in connection with scientific research, manufacturing, how to make our administrative process more effective and the latest item on our agenda: digitalization. EGIS | EGIS IN RUSSIA Egis in Russia. We have more than 65 years of work in Russian market. All the while, we have been committing to the main strategy, which is based on traditionally close relationship with Russian healthcare professionals, as well as the obligation to provide the latest therapies, products of the highest quality for a wider group of people

in Russia.

EGIS | HOME

The main page of Egis' international website. Innovation Study on Neuroscience Research wins Egis’ Prize this Year. As research and development are fundamental pillars of our strategy Egis is deeply committed to raise students’ interest in science and help the promising young minds develop their talents. EGIS | PHARMA COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | BIOSIMILAR PRODUCTS Biological therapies made a breakthrough in the treatment of diseases that were incurable or difficult to cure before (e.g. cancer or chronic inflammation). EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Its aim is to analyse the chemical structure, physical characteristics, purity and stability of the selected active substance candidates, and to choose the most suitable form

EGIS | MANAGEMENT

Professional Experience Director of Human Resources Qualification: Teacher of Russian and English language and history (Eger, Miskolc), Certified Human Resource Manager, Doctorate School of the National University of Public Service, Generation research and development performance management and HR controlling expert EGIS | EGIS IS THE GOLDEN SPONSOR OF THIS YEAR’S According to our mission, we serve people with all of our skills, so that they can live a long and healthy life. That is why we chose to support the comprehensive nationwide screening program as a Golden Sponsor in 2019. The state-of-the-art screening truck will tour around the country until Christmas, stopping by 200 spots to offer screenings in 37 different areas. EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients.

EGIS | FLAMMEGIS

This section of the Egis Pharmaceuticals PLC site contains professional specialized information about medicines, their properties, uses and possible contraindications and

EGIS | HOME

The main page of Egis' website. One of the pillars of our corporate culture is innovation. We do not only talk about it, but enjusre the flow of ideas with annual forums that offer space for making proposals in connection with scientific research, manufacturing, how to make our administrative process more effective and the latest item on our agenda: digitalization. EGIS | EGIS IN RUSSIA Egis in Russia. We have more than 65 years of work in Russian market. All the while, we have been committing to the main strategy, which is based on traditionally close relationship with Russian healthcare professionals, as well as the obligation to provide the latest therapies, products of the highest quality for a wider group of people

in Russia.

EGIS | BIOSIMILAR PRODUCTS Biological therapies made a breakthrough in the treatment of diseases that were incurable or difficult to cure before (e.g. cancer or chronic inflammation). EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Its aim is to analyse the chemical structure, physical characteristics, purity and stability of the selected active substance candidates, and to choose the most suitable form EGIS | FŐOLDALTRANSLATE THIS PAGE Egis a világban Köszönjük, tanárnő! Köszönjük tanár úr! Pedagógusnap alkalmából köszöntjük a tanítókat, tanárokat, köszönjük nekik, hogy bevezettek a természettudományok, a kémia

titkaiba.

EGIS | COMPANY PROFILE We are one of the leading generic pharmaceutical companies in Central Eastern Europe, and our activities incorporate all areas of the pharmaceutical value chain.Egis is a member of the Servier Group, an international pharmaceutical company governed by a non-profit foundation with its headquarters in France. In the 2019/2020 financial year, Egis Group generated net sales of EUR 542 million.

EGIS | FLAMMEGIS

This section of the Egis Pharmaceuticals PLC site contains professional specialized information about medicines, their properties, uses and possible contraindications and EGIS | PHARMACEUTICAL COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

EGIS | OTC PRODUCTS

OTC is the abbreviation for "over the counter". It refers to no-prescription products.

EGIS | EGIS HISTORY

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

EGIS | EGIS WORLD

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | VEZETŐSÉGTRANSLATE THIS PAGE gazdasági igazgató. Végzettség: Közgazdász (BKE) Tapasztalatok: 2008 - 2011 Stratégiai kontrolling vezető, Egis. 2003 - 2008 Gazdasági igazgató, Béres Gyógyszergyár

EGIS | HOME

Egis Health and Prevention Days in Kőbánya. In parallel to our mission, we serve people with all our knowledge and skills, so that they can live a long and healthy life. As Diamond Sponsor of the comprehensive nationwide health tests program, Egis Pharmaceuticals is devotedly engaged in the improvement of the Hungarian healthcare. EGIS | PHARMA COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | BIOSIMILAR PRODUCTS Since 2013, we have launched four biosimilar products for the therapy of autoimmune, oncology and oncohematology illnesses. From 2010 onwards, we have carried out infrastructure developments at our site in Budapest for this entirely new pharmaceutical area—and have acquired new expertise regarding the analysis, packaging, storage,

logistics

EGIS | SALES AND MARKETING End of dialog window. Sales and Marketing. Our products are available in over 60 countries; 76% of our revenue is derived from export, 24% from our domestic market. Owing to the well-coordinated operations of our sites in Hungary, our extensive network of external markets, and our subsidiaries and offices operating in 17 countries, we are able EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients. As for HP active ingredients, our employees work completely separated from the substances and use special gloves to manipulate the instruments and equipment EGIS | EGIS IS THE GOLDEN SPONSOR OF THIS YEAR’S The state-of-the-art screening truck will tour around the country until Christmas, stopping by 200 spots to offer screenings in 37 different areas. Health. Egis is the Golden Sponsor of this Year’s Nationwide Public Health Screening. According to our mission, we serve people with all of our skills, so that they can live a long and

healthy life.

EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients.

EGIS | HOME

Egis World. Discover the Hungarian Medicine brand. It has been almost 110 years since dr. Sándor Balla, the Hungarian pharmacist fulfilled his dream and the predeccessor of Egis was established in Budapest. Ever since then, our objective has remained unchanged: to provide Hungarian medicines of the highest quality to people, so that they can EGIS | EGIS IN RUSSIA Egis in Russia. We have more than 65 years of work in Russian market. All the while, we have been committing to the main strategy, which is based on traditionally close relationship with Russian healthcare professionals, as well as the obligation to provide the latest therapies, products of the highest quality for a wider group of people

in Russia.

EGIS | VEZETŐSÉGTRANSLATE THIS PAGE Végzettség: Orvos (SOTE), szakjogász (ELTE), szakközgazdász (BKE), valamint MBA (BME) másoddiploma. Tapasztalatok: 2006 - 2009 Egis nemzetközi értékesítési és marketing igazgató. Korábban üzletág igazgató, Aventisnél & Sanofi-Aventis. Többéves mentőorvosi praktizálás után orvoslátogató, majd termékmenedzserként

EGIS | HOME

Egis Health and Prevention Days in Kőbánya. In parallel to our mission, we serve people with all our knowledge and skills, so that they can live a long and healthy life. As Diamond Sponsor of the comprehensive nationwide health tests program, Egis Pharmaceuticals is devotedly engaged in the improvement of the Hungarian healthcare. EGIS | PHARMA COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | BIOSIMILAR PRODUCTS Since 2013, we have launched four biosimilar products for the therapy of autoimmune, oncology and oncohematology illnesses. From 2010 onwards, we have carried out infrastructure developments at our site in Budapest for this entirely new pharmaceutical area—and have acquired new expertise regarding the analysis, packaging, storage,

logistics

EGIS | SALES AND MARKETING End of dialog window. Sales and Marketing. Our products are available in over 60 countries; 76% of our revenue is derived from export, 24% from our domestic market. Owing to the well-coordinated operations of our sites in Hungary, our extensive network of external markets, and our subsidiaries and offices operating in 17 countries, we are able EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients. As for HP active ingredients, our employees work completely separated from the substances and use special gloves to manipulate the instruments and equipment EGIS | EGIS IS THE GOLDEN SPONSOR OF THIS YEAR’S The state-of-the-art screening truck will tour around the country until Christmas, stopping by 200 spots to offer screenings in 37 different areas. Health. Egis is the Golden Sponsor of this Year’s Nationwide Public Health Screening. According to our mission, we serve people with all of our skills, so that they can live a long and

healthy life.

EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients.

EGIS | HOME

Egis World. Discover the Hungarian Medicine brand. It has been almost 110 years since dr. Sándor Balla, the Hungarian pharmacist fulfilled his dream and the predeccessor of Egis was established in Budapest. Ever since then, our objective has remained unchanged: to provide Hungarian medicines of the highest quality to people, so that they can EGIS | EGIS IN RUSSIA Egis in Russia. We have more than 65 years of work in Russian market. All the while, we have been committing to the main strategy, which is based on traditionally close relationship with Russian healthcare professionals, as well as the obligation to provide the latest therapies, products of the highest quality for a wider group of people

in Russia.

EGIS | VEZETŐSÉGTRANSLATE THIS PAGE Végzettség: Orvos (SOTE), szakjogász (ELTE), szakközgazdász (BKE), valamint MBA (BME) másoddiploma. Tapasztalatok: 2006 - 2009 Egis nemzetközi értékesítési és marketing igazgató. Korábban üzletág igazgató, Aventisnél & Sanofi-Aventis. Többéves mentőorvosi praktizálás után orvoslátogató, majd termékmenedzserként EGIS | BIOSIMILAR PRODUCTS Since 2013, we have launched four biosimilar products for the therapy of autoimmune, oncology and oncohematology illnesses. From 2010 onwards, we have carried out infrastructure developments at our site in Budapest for this entirely new pharmaceutical area—and have acquired new expertise regarding the analysis, packaging, storage,

logistics

EGIS | PRODUCTS

Prescription products. The majority of our portfolio consists of prescription products that can improve the quality of life for patients suffering with cardiovascular or central nervous system diseases. We are traditionally among the leaders in these two therapeutic areas in Hungary*, and we are continuously exploring new therapeutic areas so EGIS | FŐOLDALTRANSLATE THIS PAGE Kutatás-fejlesztés. Stratégiánk egyik alappillére az innováció. A 2019/2020-as üzleti évben mintegy 16 milliárd forintot költöttük kutatás-fejlesztésre. A részletekért kattintson ide. Egis a világban Gyógyszeripari vállalat K+F. Saját leányvállalat, képviselet. Értékesítés partnereken keresztül.

Kapcsolat.

EGIS | MANAGEMENT

During the more than 100 years since its establishment, Egis has become a leading generic pharmaceutical company in the Central Eastern European region. The composition of our corporate management demonstrates our activities, which extend to every field of the pharmaceutical value chain: from research and development, through

production to

EGIS | OTC PRODUCTS

Here you can find out more about our over-the-counter products. Click on the link and learn about our non-prescription portfolio. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a

valid

EGIS | PHARMACEUTICAL COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

EGIS | EGIS WORLD

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

EGIS | SINDRANOL®

Contacts. Sindranol®. For Healthcare professionals only. In accordance with the Russian Legislation Egis provides Rx product information for use by healthcare professionals only. The information below is for Russian healthcare professionals. Please confirm that you are a medical or pharmaceutical worker and agree to the above rules

for the use

EGIS | LICENSING ACTIVITIES Licensing activities. When entering new markets and new therapeutic areas, we are supported by our licensing activities — which have been a part of our company tradition for several decades. The marketing of our own developed and manufactured medicines in non-strategic markets, i.e. those where we are not present with our

own subsidiaries or

EGIS | VEZETŐSÉGTRANSLATE THIS PAGE Végzettség: Orvos (SOTE), szakjogász (ELTE), szakközgazdász (BKE), valamint MBA (BME) másoddiploma. Tapasztalatok: 2006 - 2009 Egis nemzetközi értékesítési és marketing igazgató. Korábban üzletág igazgató, Aventisnél & Sanofi-Aventis. Többéves mentőorvosi praktizálás után orvoslátogató, majd termékmenedzserként

EGIS | HOME

The main page of Egis' international website. Innovation Study on Neuroscience Research wins Egis’ Prize this Year. As research and development are fundamental pillars of our strategy Egis is deeply committed to raise students’ interest in science and help the promising young minds develop their talents. EGIS | PHARMA COMPANYEGIS COMPANYALLEGIS PHARMAEGIS GYOGYSZERGYAR ZRTEGIS PHARMACEUTICALS PLCEGIS PORTALEGIS PHARMACEUTICALS PLC HUNGARY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | BIOSIMILAR PRODUCTS Biological therapies made a breakthrough in the treatment of diseases that were incurable or difficult to cure before (e.g. cancer or chronic inflammation). EGIS | SALES AND MARKETING Our products are available in over 60 countries; 76% of our revenue is derived from export, 24% from our domestic market. Owing to the well-coordinated operations of our sites in Hungary, our extensive network of external markets, and our subsidiaries and offices operating in 17 countries, we are able to contribute to the treatment of approximately 30 million patients. EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Its aim is to analyse the chemical structure, physical characteristics, purity and stability of the selected active substance candidates, and to choose the most suitable form EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients.

EGIS | MANAGEMENT

Professional Experience Director of Human Resources Qualification: Teacher of Russian and English language and history (Eger, Miskolc), Certified Human Resource Manager, Doctorate School of the National University of Public Service, Generation research and development performance management and HR controlling expert EGIS | EGIS IS THE GOLDEN SPONSOR OF THIS YEAR’S According to our mission, we serve people with all of our skills, so that they can live a long and healthy life. That is why we chose to support the comprehensive nationwide screening program as a Golden Sponsor in 2019. The state-of-the-art screening truck will tour around the country until Christmas, stopping by 200 spots to offer screenings in 37 different areas.

EGIS | HOME

The main page of Egis' website. One of the pillars of our corporate culture is innovation. We do not only talk about it, but enjusre the flow of ideas with annual forums that offer space for making proposals in connection with scientific research, manufacturing, how to make our administrative process more effective and the latest item on our agenda: digitalization. EGIS | EGIS IN RUSSIA Egis in Russia. We have more than 65 years of work in Russian market. All the while, we have been committing to the main strategy, which is based on traditionally close relationship with Russian healthcare professionals, as well as the obligation to provide the latest therapies, products of the highest quality for a wider group of people

in Russia.

EGIS | HOME

The main page of Egis' international website. Innovation Study on Neuroscience Research wins Egis’ Prize this Year. As research and development are fundamental pillars of our strategy Egis is deeply committed to raise students’ interest in science and help the promising young minds develop their talents. EGIS | PHARMA COMPANYEGIS COMPANYALLEGIS PHARMAEGIS GYOGYSZERGYAR ZRTEGIS PHARMACEUTICALS PLCEGIS PORTALEGIS PHARMACEUTICALS PLC HUNGARY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | BIOSIMILAR PRODUCTS Biological therapies made a breakthrough in the treatment of diseases that were incurable or difficult to cure before (e.g. cancer or chronic inflammation). EGIS | SALES AND MARKETING Our products are available in over 60 countries; 76% of our revenue is derived from export, 24% from our domestic market. Owing to the well-coordinated operations of our sites in Hungary, our extensive network of external markets, and our subsidiaries and offices operating in 17 countries, we are able to contribute to the treatment of approximately 30 million patients. EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Its aim is to analyse the chemical structure, physical characteristics, purity and stability of the selected active substance candidates, and to choose the most suitable form EGIS | - DEVELOPMENT OF ACTIVE INGREDIENTS Development of active ingredients. We have established the cutting-edge infrastructure required for the development of both traditional and so-called highly potent (HP) active ingredients.

EGIS | MANAGEMENT

Professional Experience Director of Human Resources Qualification: Teacher of Russian and English language and history (Eger, Miskolc), Certified Human Resource Manager, Doctorate School of the National University of Public Service, Generation research and development performance management and HR controlling expert EGIS | EGIS IS THE GOLDEN SPONSOR OF THIS YEAR’S According to our mission, we serve people with all of our skills, so that they can live a long and healthy life. That is why we chose to support the comprehensive nationwide screening program as a Golden Sponsor in 2019. The state-of-the-art screening truck will tour around the country until Christmas, stopping by 200 spots to offer screenings in 37 different areas.

EGIS | HOME

The main page of Egis' website. One of the pillars of our corporate culture is innovation. We do not only talk about it, but enjusre the flow of ideas with annual forums that offer space for making proposals in connection with scientific research, manufacturing, how to make our administrative process more effective and the latest item on our agenda: digitalization. EGIS | EGIS IN RUSSIA Egis in Russia. We have more than 65 years of work in Russian market. All the while, we have been committing to the main strategy, which is based on traditionally close relationship with Russian healthcare professionals, as well as the obligation to provide the latest therapies, products of the highest quality for a wider group of people

in Russia.

EGIS | BIOSIMILAR PRODUCTS Biological therapies made a breakthrough in the treatment of diseases that were incurable or difficult to cure before (e.g. cancer or chronic inflammation).

EGIS | MANAGEMENT

Professional Experience Director of Human Resources Qualification: Teacher of Russian and English language and history (Eger, Miskolc), Certified Human Resource Manager, Doctorate School of the National University of Public Service, Generation research and development performance management and HR controlling expert

EGIS | FŐOLDAL

Egis a világban Köszönjük, tanárnő! Köszönjük tanár úr! Pedagógusnap alkalmából köszöntjük a tanítókat, tanárokat, köszönjük nekik, hogy bevezettek a természettudományok, a kémia

titkaiba.

EGIS | PRODUCTS

OTC is the abbreviation for "over the counter". It refers to products available without prescription. However, it is always important to follow the instructions and consult with your physician or pharmacist before choosing an OTC item.

EGIS | OTC PRODUCTS

OTC is the abbreviation for "over the counter". It refers to no-prescription products. EGIS | PHARMACEUTICAL COMPANY Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

EGIS | EGIS WORLD

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. EGIS | LICENSING ACTIVITIES Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

EGIS | SINDRANOL®

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

EGIS | VEZETŐSÉG

gazdasági igazgató. Végzettség: Közgazdász (BKE) Tapasztalatok: 2008 - 2011 Stratégiai kontrolling vezető, Egis. 2003 - 2008 Gazdasági igazgató, Béres Gyógyszergyár

EGIS IN THE WORLD

Our products are available in 65 countries Click here to learn more

PHARMA COMPANY

Our activities incorporate all areas of the pharmaceutical value chain Click here to learn more RESEARCH & DEVELOPMENT Innovation is one of the pillars of our strategy. We devote approximately EUR 50 million to research and development. Click here to learn more Egis World Pharma Company R&D Own subsidiaries / Representative offices Sales through Partners

__ __

Contact __ __

__

* About Us __ __

* Management

* Company Profile

* Pharma Company

* Egis World

* Egis History

* Awards and Prizes

* CSR - Corporate Social Responsibility

* Activities __ __

* Research & Development * - Development of active ingredients * - Finished Product Development * Finished Product Manufacturing * Manufacturing Active Substances * Biosimilar Products

* Packaging

* Sales and Marketing * Licensing activities

* Products

* Magazine

* Career __ __

* A place to work

* Interactive

__ __

Websites in other countries

* Armenia

* Azerbaijan

* Belarus

* Bulgaria

* Czech Republic

* Georgia

* Hungary

* Kazakhstan

* Latvia

* Lithuania

* Moldova

* Poland

* Romania

* Russia

* Slovakia

* Ukraine

* Uzbekistan

* Vietnam

International Egis Website

__

__

__ __

__ __

__

Websites in other countries

* Armenia

* Azerbaijan

* Belarus

* Bulgaria

* Czech Republic

* Georgia

* Hungary

* Kazakhstan

* Latvia

* Lithuania

* Moldova

* Poland

* Romania

* Russia

* Slovakia

* Ukraine

* Uzbekistan

* Vietnam

International Egis Website

* Home

* About Us __ __

* Management

* Company Profile

* Pharma Company

* Egis World

* Egis History

* Awards and Prizes

* CSR - Corporate Social Responsibility

* Activities __ __

* Research & Development * - Development of active ingredients * - Finished Product Development * Finished Product Manufacturing * Manufacturing Active Substances * Biosimilar Products

* Packaging

* Sales and Marketing * Licensing activities

* Products

* Magazine

* Career __ __

* A place to work

* Interactive

* Contact

EGIS HAS BEEN RECOGNIZED AS A ’FUTURE PROOF ORGANIZATION’ NEW UNIT INAUGURATED AT EGIS’S KÖRMEND PLANT EGIS COLLEAGUE WINS NINE MEDALS IN ATHLETICS AT THE 40TH WORLD MEDICAL

& HEALTH GAMES

OUR PEOPLE

INTERVIEW WITH ISTVÁN HODÁSZ (CEO EGIS) ON PHARMABOARDROOM PharmaBoardroom is a site for senior professionals, providing global news, trends and reports relating to the pharmaceutical industry.

More

More articles on OUR PEOPLE (5)

__

HEALTH

THE CONTINUOUS OPERATION OF EGIS IS VITAL The quality of life of millions depends on the availability of our medicines. Egis is one of the leading generic pharmaceutical companies in Central Easter Europe. We produce approximately 170 million boxes of drugs, 700 tonnes of active pharmaceutical ingredients, 5 billion tablets, capsules annually. Our products are available in 65 countries, and annually more than 30 million patients’ recovery depends on Egis Group’s continuous operation.

More

More articles on HEALTH (5)

__

HEALTH

WASH YOUR HANDS THE RIGHT WAY WHO has created a six-step protocol: by applying this method, we can remove the germs, viruses, and bacteria from the surface of our hands.

More

More articles on HEALTH (5)

__

INNOVATION

STRATEGIC COOPERATION AGREEMENT BETWEEN SEMMELWEIS UNIVERSITY AND EGIS The Semmelweis University and Egis Pharmaceuticals PLC have agreed on an even closer cooperation than before. Our common goal is to further raise the standards of pharmaceutical R+D as well as pharmacist and doctor training by making use of the synergies in each other’s activities. As a result of the agreement, new health industrial innovations can be launched and the Semmelweis University can be extended with more practical educational and training elements that also meet the needs of the Hungarian pharmaceutical industry.

More

More articles on INNOVATION (6)

__

EGIS WORLD

PHARMACEUTICAL INDUSTRY PLAYS A KEY ROLE The pharmaceutical industry plays a key role in the Hungarian economy’s change of dimension.

More

More articles on EGIS WORLD (7)

__

EGIS WORLD

EGIS AWARDED FOR ITS INTERNAL CSR ACTIVITIES To support the CSR activities of local companies, the Hungarian Business Responsibility founded its special awards, called CSR Hungary. This year, Egis was awarded in the ‘Inner CSR Solutions’ category that comes with a two-year trademark right.

More

More articles on EGIS WORLD (7)

__

INNOVATION

EGIS HAS BEEN RECOGNIZED AS A ’FUTURE PROOF ORGANIZATION’ Microsoft and HR Fest — the largest HR professional festival in Hungary — established a new professional award category within HR Best awards called ‘Future Proof Organizations’.

More

More articles on INNOVATION (6)

__

INNOVATION

NEW UNIT INAUGURATED AT EGIS’S KÖRMEND PLANT Egis and our consortia partners have won 2,332 billion HUF direct grant in the framework of the innovation tender GINOP-2.2.1-15-2016-00023 for the realisation of the above-mentioned

project.

More

More articles on INNOVATION (6)

__

OUR PEOPLE

EGIS COLLEAGUE WINS NINE MEDALS IN ATHLETICS AT THE 40TH WORLD MEDICAL

& HEALTH GAMES

Egis Pharmaceutical PLC’s Senior pharmaceutical sales rep participated very successfully at Medigames. Having won two gold medals, four silvers, and three bronze, pharmacist Dr. Judit Karagics contributed considerably to the 3rd place Hungary reached in the medal table. This excellent performance strengthens Egis’ reputation in the international target groups.

More

More articles on OUR PEOPLE (5)

__

STRATEGIC COOPERATION AGREEMENT BETWEEN SEMMELWEIS UNIVERSITY AND EGIS PHARMACEUTICAL INDUSTRY PLAYS A KEY ROLE EGIS AWARDED FOR ITS INTERNAL CSR ACTIVITIES EGIS’ PRODUCTS ARE AVAILABLE IN 65 COUNTRIES AROUND THE WORLD. Egis ’products are available in 65 COUNTRIES. Our portfolio consists of 629 PRODUCTS.  Our main focus lies on treating diseases of the CARDIOVASCULAR AND CENTRAL NERVOUS SYSTEMS. Learn more about our products

Therapeutic areas

Therapeutic areas

Cardiovascular system Central nervous system

Gastroenterology

Oncology

Women´s health

GALLERY

DOWNLOADS

OUR RELATED PRODUCTS

More __

Quick news

Jan 31.

PART OF GYÓGYSZERGYÁRI STREET RENAMED AFTER ISTVÁN ORBÁN On 29 January, based on the unanimous decision of the General Assembly of Budapest, a part of Kőbánya’s (10th District of Budapest) Gyógyszergyári Street was renamed and from now on pays tribute to our beloved former CEO, István Orbán.

More

Jun 14.

THREE EGIS SUBSIDIARIES AMONG THE BEST EMPLOYERS Following the success of Egis Russia and Egis Polska, we are proud to announce that Egis Praha has also been recognized as Best Employer at Aon Hewitt’s Employee Engagement Survey.

More

Jun 13.

EGIS STRENGTHENS EUROPEAN PRESENCE IN THE BIOSIMILAR AREA Hungarian-based Egis Pharmaceuticals PLC signed an exclusive distribution agreement with Mundipharma network for a pegfilgrastim biosimilar. Pursuant to the agreement, Egis gains the exclusive distribution rights related to the medicine used to reduce a common side effect of cancer treatment called neutropenia and the related life-threatening infections.

More

Jun 10.

EGIS RUSSIA WINS PRESTIGIOUS AWARD FOR CSR CAMPAIGN Egis Russia’s Buy for Good campaign that was carried out in 2018 won the award of ‘Best Social Projects in Russia’ in the category of medical and social projects.

More

Apr 24.

WHEN CREATIVE MINDS MEET One of the pillars of our corporate culture is innovation. We do not only talk about it, but enjusre the flow of ideas with annual forums that offer space for making proposals in connection with scientific research, manufacturing, how to make our administrative process more effective and the latest item on our agenda: digitalization.

More

Apr 09.

A JOURNEY TO THE EMPIRE OF HEALTH This March, the Hungarian Nationwide Public Health Screening Program’s special campaign sets off to teach children about health maintenance and prevention measures.

More

Contact __ __

* About Us

* Management

* Company Profile

* Pharma Company

* Egis World

* Egis History

* Awards and Prizes

* CSR - Corporate Social Responsibility

* Transparency

* For Investors

* Investor News

* Activities

* Research & Development * - Development of active ingredients * - Finished Product Development * Manufacturing Active Substances * Finished Product Manufacturing * Biosimilar Products

* Packaging

* Sales and Marketing * Licensing activities

* Products

* Products Overview

* Principles of Pharmacovigilance

*

* Magazine

* A place to work

* Interactive

*

* Contact

* Imprint

* Privacy Policy

* Cookies policy

* Legal notice

* Cookie Settings

__

Play video

Please, allow JavaScript on your browser, or use a modern browser, which supports HTML5 videos. Video Player is loading.Play Video

Play

Mute

Current Time 0:00

/

Duration -:-

Loaded: 0%

0:00

Stream Type LIVESeek to live, currently playing liveLIVE Remaining Time --:-

Playback Rate

1x

Chapters

* Chapters

Descriptions

* descriptions off, selected

Captions

* captions settings, opens captions settings dialog * captions off, selected

Audio Track

Fullscreen

This is a modal window. Beginning of dialog window. Escape will cancel and close the window. TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque Font Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps Reset restore all settings to the default valuesDoneClose Modal Dialog End of dialog window.

Show gallery

No. of employees

No. of products

Subsidiary/representation was established in

No. of employees

No. of products

Subsidiary/representation was established in

__

__ __ __ __ __ __ __

Play video

Please, allow JavaScript on your browser, or use a modern browser, which supports HTML5 videos. Video Player is loading.Play Video

Play

Mute

Current Time 0:00

/

Duration -:-

Loaded: 0%

0:00

Stream Type LIVESeek to live, currently playing liveLIVE Remaining Time --:-

Playback Rate

1x

Chapters

* Chapters

Descriptions

* descriptions off, selected

Captions

* captions settings, opens captions settings dialog * captions off, selected

Audio Track

Fullscreen

This is a modal window. Beginning of dialog window. Escape will cancel and close the window. TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque Font Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps Reset restore all settings to the default valuesDoneClose Modal Dialog End of dialog window.

Show gallery

__

Play video

Please, allow JavaScript on your browser, or use a modern browser, which supports HTML5 videos. Video Player is loading.Play Video

Play

Mute

Current Time 0:00

/

Duration -:-

Loaded: 0%

0:00

Stream Type LIVESeek to live, currently playing liveLIVE Remaining Time --:-

Playback Rate

1x

Chapters

* Chapters

Descriptions

* descriptions off, selected

Captions

* captions settings, opens captions settings dialog * captions off, selected

Audio Track

Fullscreen

This is a modal window. Beginning of dialog window. Escape will cancel and close the window. TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque Font Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps Reset restore all settings to the default valuesDoneClose Modal Dialog End of dialog window.

__

GALLERY

DOWNLOADS

OUR RELATED PRODUCTS

__

WELCOME!

You are currently viewing the international site of Egis. Would you like to see the Egis website available in your country?

No, thanks

Go!

COOKIE SETTINGS

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings. COOKIES NECESSARY FOR BASIC FUNCTIONING These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

FUNCTIONAL COOKIES

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit. COOKIES FOR STATISTICAL PURPOSES They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.

Details

I Agree

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Details

Cookie Settings

I agree

COOKIE MANAGEMENT POLICY Your browser is out of date. Please, use an updated version!

Chrome || Firefox